Recent solubility and dissolution enhancement techniques for repaglinide a BCS class II drug: a review
Repaglinide is an oral blood-glucose-lowering drug used to manage type-2 diabetes mellitus by lowering post-prandial glucose by stimulating insulin secretion from pancreatic beta cells. According to the biopharmaceutical classification system, repaglinide falls under the class II category. Fo...
Main Authors: | Saba Albetawi, Amer Abdalhafez, Ala Abu-Zaid, Aseel Matrouk, Noor Alhourani |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2021-08-01
|
Series: | Pharmacia |
Online Access: | https://pharmacia.pensoft.net/article/66586/download/pdf/ |
Similar Items
-
The Impact of Surfactant Composition and Surface Charge of Niosomes on the Oral Absorption of Repaglinide as a BCS II Model Drug
by: Yaghoobian M, et al.
Published: (2020-11-01) -
DISSOLUTION PROFILE STUDIES OF BCS CLASS II DRUG VALSARTAN BY BIOWAIVER PROCEDURE
by: E. R. Brigas, et al.
Published: (2019-01-01) -
Solubility, Permeability, and Dissolution Rate of Naftidrofuryl Oxalate Based on BCS Criteria
by: Marta Kus-Slowinska, et al.
Published: (2020-12-01) -
Equilibrium solubility versus intrinsic dissolution: characterization of lamivudine, stavudine and zidovudine for BCS classification
by: André Bersani Dezani, et al.
Published: (2013-12-01) -
Enhancing the solubility of BCS class II drugs using mesoporous silica based formulations
by: Madi, Atif M. Abdelsaiad
Published: (2016)